Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Clinical Trials/Clinical Studies

Posted on By

Standard Operating Procedure for Conducting Clinical Research

Purpose

The purpose of this SOP is to establish the standard procedures for conducting clinical trials and clinical studies to ensure compliance with regulatory requirements, ethical standards, and safety measures for participants.

Scope

This SOP applies to all personnel involved in the planning, conduct, monitoring, and reporting of clinical trials or studies. This includes researchers, clinical staff, sponsors, and regulatory bodies.

Responsibilities

  • Principal Investigator (PI): Oversees the clinical trial or study, ensuring adherence to the protocol and regulations.
  • Clinical Research Coordinators: Manage the day-to-day operations of the trial or study.
  • Data Management Team: Collects, processes, and maintains trial or study data.
  • Regulatory Affairs: Ensures compliance with regulatory requirements and reporting.
  • Ethics Committee: Reviews and approves the study protocol and consent forms.
  • Sponsors: Provide funding and support for the clinical trial or study.
See also  SOP for Safety Monitoring and Reporting

Procedure

  • Protocol Development: Design the study protocol according to scientific and ethical guidelines.
  • Regulatory Approvals: Obtain necessary approvals from regulatory bodies and ethics committees.
  • Participant Recruitment: Screen and enroll participants according to inclusion and exclusion criteria.
  • Informed Consent: Obtain informed consent from participants in writing.
  • Data Collection: Collect data according to the study protocol, ensuring accuracy and completeness.
  • Monitoring and Safety: Monitor participants’ safety and trial or study progress, reporting adverse events promptly.
  • Data Analysis: Analyze data and interpret results, ensuring accuracy and adherence to statistical methods.
  • Reporting: Prepare reports according to regulatory requirements, including interim and final study reports.
  • Archiving: Store all study documents securely for future reference.
See also  SOP for Investigator and Site Training

Abbreviations Used

  • SOP: Standard Operating Procedure
  • PI: Principal Investigator
  • IRB: Institutional Review Board
  • FDA: Food and Drug Administration

Documents

  • Study Protocol
  • Informed Consent Forms
  • Case Report Forms
  • Monitoring Reports
  • Data Analysis Reports
  • Study Reports

References

  • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)
  • Ethics committee regulations
  • Institutional policies and procedures

SOP Version

Version: 1.0

Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs Data management SOPs Electronic systems validation, clinical trials, Conflict of interest management, Data collection methods, eCRF validation, Electronic record-keeping guidelines, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

Post navigation

Previous Post: SOP for Cross-contamination Prevention
Next Post: SOP for Study Protocol Development and Approval

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version